EcoDrugPlus

Tachykinin Receptor 3

Ensembl ID : ENSHBUG00000009339
Gene Symbol: TACR3
3 Cross references
208 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSHBUG00000018794
Gene Symbol: TERT
3 Cross references
189 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSHBUG00000007287
Gene Symbol: TBXA2R
3 Cross references
192 Possible Orthologues:

Thromboxane-A Synthase-Like

Ensembl ID : ENSHBUG00000017733
Gene Symbol: LOC102294370
3 Cross references
207 Possible Orthologues:

Thromboxane-A Synthase-Like

Ensembl ID : ENSHBUG00000017683
Gene Symbol: LOC102295482
3 Cross references
209 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSHBUG00000003624
Gene Symbol: TYMP
4 Cross references
171 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSHBUG00000016669
Gene Symbol: TYMS
3 Cross references
223 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSHBUG00000013451
Gene Symbol: LOC102294177
3 Cross references
389 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSHBUG00000014873
Gene Symbol: TRHR
3 Cross references
201 Possible Orthologues:

Thyrotropin-Releasing Hormone Receptor-Like

Ensembl ID : ENSHBUG00000017993
Gene Symbol: LOC102309467
3 Cross references
193 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSHBUG00000019995
Gene Symbol: TLR2
2 Cross references
170 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSHBUG00000022613
Gene Symbol: TLR7
3 Cross references
197 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).